🎗️ GTN FIGO Anatomic Stage
UseAnatomic staging of GTN, used jointly with the prognostic score to guide single-agent vs combination chemothe…
SourceFIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynaecol …
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Stage and prognostic score are reported together (e.g. III:7); stage alone does not determine treatment.
When to use
Anatomic staging of GTN, used jointly with the prognostic score to guide single-agent vs combination chemotherapy.
How it works
I confined to uterus; II outside uterus but limited to genital structures (adnexa/vagina/broad ligament); III lung metastasis (± genital tract); IV other distant (brain/liver/kidney/GI). Expressed with the prognostic score as Stage:Score.
Key points
- Stage and prognostic score are reported together (e.g. III:7); stage alone does not determine treatment.
- GTN has no regional nodal staging — nodal disease is classed as M1b and is uncommon.
- Prognostic score ≤ 6 is low-risk (single-agent MTX/actinomycin D); ≥ 7 is high-risk (combination, e.g. EMA-CO).
- Even stage IV GTN has a relatively good prognosis compared with other solid tumours, especially lung-only disease.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Extent of disease | Outside uterus, limited to genital structures: adnexa/vagina/broad ligament (II) |
|---|
→FIGO anatomic stageStage II
- Anatomic stage:Stage II: outside uterus, limited to genital structures (adnexa, vagina, broad ligament)
- Expression:Anatomic stage (Roman I–IV) + WHO/FIGO prognostic score (Arabic) are expressed together, e.g. 「III:7」; score ≤ 6 low-risk, ≥ 7 high-risk (see the GTN prognostic score tool)
- Treatment link:Low-risk (score ≤ 6) usually uses single-agent chemotherapy (MTX/actinomycin D); high-risk (≥ 7) or with high-risk features uses combination chemotherapy (EMA-CO); brain/liver metastasis is individualised (radiation/surgery/intrathecal MTX)
| Extent of disease | Confined to uterus (I) |
|---|
→FIGO anatomic stageStage I
- Anatomic stage:Stage I: confined to uterus
- Expression:Anatomic stage (Roman I–IV) + WHO/FIGO prognostic score (Arabic) are expressed together, e.g. 「III:7」; score ≤ 6 low-risk, ≥ 7 high-risk (see the GTN prognostic score tool)
- Treatment link:Low-risk (score ≤ 6) usually uses single-agent chemotherapy (MTX/actinomycin D); high-risk (≥ 7) or with high-risk features uses combination chemotherapy (EMA-CO); brain/liver metastasis is individualised (radiation/surgery/intrathecal MTX)
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using GTN FIGO Anatomic Stage?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does GTN FIGO Anatomic Stage upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is GTN FIGO Anatomic Stage calculated in practice? Can you show a worked example?
- Inputs: Extent of disease Outside uterus, limited to genital structures: adnexa/vagina/broad ligament (II) → Result: FIGO anatomic stage Stage II(Anatomic stage: Stage II: outside uterus, limited to genital structures (adnexa, vagina, broad ligament), Expression: Anatomic stage (Roman I–IV) + WHO/FIGO prognostic score (Arabic) are expressed together, e.g. 「III:7」; score ≤ 6 low-risk, ≥ 7 high-risk (see the GTN prognostic score tool), Treatment link: Low-risk (score ≤ 6) usually uses single-agent chemotherapy (MTX/actinomycin D); high-risk (≥ 7) or with high-risk features uses combination chemotherapy (EMA-CO); brain/liver metastasis is individualised (radiation/surgery/intrathecal MTX)) Inputs: Extent of disease Confined to uterus (I) → Result: FIGO anatomic stage Stage I(Anatomic stage: Stage I: confined to uterus, Expression: Anatomic stage (Roman I–IV) + WHO/FIGO prognostic score (Arabic) are expressed together, e.g. 「III:7」; score ≤ 6 low-risk, ≥ 7 high-risk (see the GTN prognostic score tool), Treatment link: Low-risk (score ≤ 6) usually uses single-agent chemotherapy (MTX/actinomycin D); high-risk (≥ 7) or with high-risk features uses combination chemotherapy (EMA-CO); brain/liver metastasis is individualised (radiation/surgery/intrathecal MTX))